XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.3

Business Segments (Tables)

3 Months Ended

Sep. 30, 2025

Business Segments

Schedule of information regarding reportable segments

​

​	​	​	​	​	​	​
​		Three Months
For the Periods Ended September 30		2025			2024
Net sales
Animal Health	​	$	283,456	​	$	182,523
Mineral Nutrition	​		62,988	​		59,062
Performance Products	​		17,449	​		18,847
Total segments	​	$	363,893	​	$	260,432

​

​

​	​	​	​	​	​	​
​	​	Three Months
For the Periods Ended September 30		2025		​	2024
Animal Health	​	​	​	​	​	​
Net sales		$	283,456	​	$	182,523
Cost of sales	​	​	172,872	​	​	108,239
Selling, general and administrative expenses (1)	​	​	47,251	​	​	41,562
Add: Depreciation and amortization	​	​	11,599	​	​	7,663
Add: Acquisition-related cost of goods sold (2)	​	​	1,117	​	​	—
Subtract: Insurance proceeds (4)	​	​	(1,177)	​	​	—
Adjusted EBITDA	​	​	74,872	​	​	40,385
​	​	​	​	​	​	​
Mineral Nutrition	​	​	​	​	​	​
Net sales		​	62,988	​	​	59,062
Cost of sales	​	​	57,284	​	​	53,887
Selling, general and administrative expenses (1)	​	​	1,715	​	​	1,929
Add: Depreciation and amortization	​	​	534	​	​	516
Adjusted EBITDA	​	​	4,523	​	​	3,762
​	​	​	​	​	​	​
Performance Products	​	​	​	​	​	​
Net sales		​	17,449	​	​	18,847
Cost of sales	​	​	13,954	​	​	14,818
Selling, general and administrative expenses (1)	​	​	2,118	​	​	2,074
Add: Depreciation and amortization	​	​	226	​	​	333
Adjusted EBITDA	​	​	1,603	​	​	2,288
​	​	​	​	​	​	​
Adjusted EBITDA – Total segments	​	$	80,998	​	$	46,435
Reconciliation of Adjusted EBITDA to income before income taxes:	​	​	​	​	​	​
Less:	​	​	​	​	​	​
Interest expense, net	​		12,059	​		7,641
Depreciation and amortization – Total segments	​		12,359	​		8,512
Depreciation and amortization – Corporate	​		471	​		492
Corporate costs	​	​	19,140	​	​	15,779
Acquisition-related cost of goods sold	​		1,117	​		—
Acquisition-related transaction costs	​		258	​		3,424
Stock-based compensation expense - named executive officer awards granted in fiscal year 2024	​		179	​		179
Phibro Forward income growth initiatives implementation costs - SG&A (3)	​	​	—	​	​	350
Insurance proceeds (4)	​	​	(3,786)	​	​	—
Foreign currency losses, net	​		2,934	​		438
Income before income taxes	​	$	36,267	​	$	9,620

​

(1) Selling, general, and administrative expenses primarily include compensation-related expenses for employees not directly involved in the production and sale of inventory, rent expenses, research and development costs, marketing expenses, and other general and administrative expenses.

(2) Represents cost of goods sold related to the stepped-up value of inventory obtained in acquisitions.

(3) Phibro Forward is a company-wide initiative focused on unlocking additional areas of revenue growth and cost savings.

(4) Represents insurance settlement gains, which are recorded within selling, general and administrative expenses.

​

​

Schedule of geographic location of property, plant and equipment, net and operating lease ROU assets

​

​	​	​	​	​	​	​
​	​	September 30,		​	June 30,
As of		2025			2025
Property, plant and equipment, net and ROU operating lease assets		​			​
United States	​	$	238,006	​	$	239,874
Israel	​		74,069	​		74,403
Brazil	​		35,394	​		34,504
Ireland	​	​	25,399	​	​	25,141
Other	​		22,058	​		22,107
​	​	$	394,926	​	$	396,029

X

- Definition

Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration